Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism NR4A2 agonists(nuclear receptor subfamily 4 group A member 2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Parkinson Disease | Preclinical | Cyprus | 22 Feb 2024 |





